A new tablet (Wonder Pill) that has been introduced as an innovative invention, reducing the risk of death from lung cancer by 50 percent, is raising hopes.
New York: A new tablet (Wonder Pill) that has been introduced as an innovative invention, reducing the risk of dying from lung cancer by 50 percent, is raising hopes. This wonder pill has become a beacon of hope for cancer patients with positive results in clinical trials conducted worldwide for ten years. This matter has come to light in the results of the survey revealed at the annual meeting of the American Society of Clinical Oncology held in Chicago.
Osimertinib, a drug to be marketed as Tagriso, has been found to be effective in lung cancer patients. Meanwhile, this drug was developed by AstraZeneca. Lung cancer is the most common cause of cancer deaths, and 18 lakh people die of lung cancer every year.
Study author Dr. Roy Herbst, deputy director of the Yale Cancer Center, said that what we could not do 30 years ago to relieve these patients. He said that this drug has now come forward in the treatment of lung cancer, and it is a wonderful drug that can reduce the death rate of fifty percent in fatal diseases such as lung cancer that does not yield to therapies. He said that this drug has been tested on patients in 26 countries.
.